Selected passages from the FDA letter
Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.
Passage 1Furthermore, this product is a misbranded drug under section 502 of the FD&C Act, 21 U.S.C. § 352.
Passage 2Some examples of the claims on your websites that establish the intended use of your products and misleadingly represent them as safe and/or effective for the treatment or prevention of COVID-19 include: